Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06432985 · ClinicalTrials.gov registry record · NA

Smoking Cessation CM for Veterans With or at Risk for Cancer

A NA study of Tobacco Use Disorder and Substance Use Disorder, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT06432985: Recruiting NA study of Tobacco Use Disorder and Substance Use Disorder, sponsored by VA Office of Research and Development.

NCT06432985 is a NA study of Tobacco Use Disorder and Substance Use Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 108 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06432985, a NA study of Tobacco Use Disorder and Substance Use Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clinics. CM is a behavioral treatment that uses rewards to encourage smoking cessation when verified through biological testing. In the first year, the researchers will develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. In the second year, they will conduct a pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans over a five-week period. The success of the pilot study will determine whether to proceed with a larger randomized controlled trial (RCT) in years three to six, comparing the efficacy of mobile CM with standard treatment. The project will take place at SFVA.

Primary Outcome

Audio recordings will be analyzed by the research team using a template-based rapid analysis technique developed for health services research. A structured summary will be prepared, organized by topical areas drawn from the interview/focus group guide, to identify and describe themes within each topical domain.

Interventions

  • BEHAVIORAL Focus Group
  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Behavioral Counseling (Cognitive Behavioral Therapy, CBT)
  • BEHAVIORAL TUD Treatment as Usual (TAU)

Study Locations (1)

California

  • San Francisco VA Medical Center, San Francisco, CA - San Francisco

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-01-29
Est. Completion 2031-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06432985 shows while recruiting

NCT06432985 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (55% lower).

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Focus Group is the first listed.

NCT06432985 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06432985 about?

NCT06432985 is a clinical study titled "Smoking Cessation CM for Veterans With or at Risk for Cancer". Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clin...

What is the current status of trial NCT06432985?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-01-29. Estimated completion is 2031-09-30.

What conditions does trial NCT06432985 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Substance Use Disorder.

What interventions are being tested in trial NCT06432985?

The interventions under investigation include: Focus Group (BEHAVIORAL), Contingency Management (BEHAVIORAL), Behavioral Counseling (Cognitive Behavioral Therapy, CBT) (BEHAVIORAL), TUD Treatment as Usual (TAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06432985?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06432985 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06432985's enrollment target sits among peer trials

108 36th of 70 higher than 35 of 70 other Tobacco Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06432985, the US trial registry maintained by the National Library of Medicine. NCT06432985 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.